XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Unaudited Condensed Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities    
Net loss $ (43,788) $ (48,218)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 10,933 7,829
Amortization of right-of-use asset 852 0
Amortization of debt issuance costs 112 1,273
Amortization of prior hedge effectiveness 0 3,076
Impairment of other equity securities 170 0
Impairment of long-lived assets 0 379
Stock-based compensation 44,712 48,584
Deferred income taxes 1,955 (1,612)
Change in fair value of financial guarantee 0 (150)
Change in fair value of derivative instruments 0 28
Change in fair value of contingent consideration (150) 0
Unrealized foreign exchange loss (gain) 3,405 (401)
Other (1) 4
Changes in operating assets and liabilities:    
Accounts receivable (2,357) (2,308)
Prepaid expenses and other current assets (417) (1,693)
Other assets (345) (668)
Accounts payable (13,553) 7,891
Accrued expenses and other liabilities 8,156 3,195
Operating lease liabilities (1,642) 0
Income tax payable 15 (276)
Deferred revenue 16,700 23,763
Net cash provided by operating activities 24,757 40,696
Cash flows from investing activities    
Proceeds from acquisition working capital adjustment 307 0
Purchase of property and equipment (10,379) (6,004)
Net cash used in investing activities (10,072) (6,004)
Cash flows from financing activities    
Repayment of capital lease obligations 0 (16)
Repayment of 2018 Term Loan 0 (2,675)
Repayment of hybrid debt 0 (1,332)
Payment of initial public offering costs 0 (2,794)
Payment of contingent consideration (600) (500)
Payment of special dividends 0 (47)
Repurchase of common stock (39,155) 0
Shares surrendered for settlement of minimum statutory tax withholding (30) (209)
Proceeds from issuance of stock under employee stock plans 1,487 327
Net cash used in financing activities (38,298) (7,246)
Effect of exchange rate changes on cash and cash equivalents (147) 56
Net (decrease) increase in cash and cash equivalents, and restricted cash equivalents (23,760) 27,502
Cash and cash equivalents, and restricted cash equivalents, at beginning of the period 239,297 139,470
Cash and cash equivalents at end of the period 215,537 166,972
Non-cash investing and financing activities    
Purchase of property and equipment included in accounts payable and accrued expenses and other current liabilities 869 584
Change in fair value of hedged interest rate swaps and interest rate cap 0 (3,133)
Capitalized stock-based compensation 1,230 13
Deferred offering costs included in accounts payable and accrued expenses and other current liabilities 0 2,678
Deferred financing costs included in accounts payable and accrued expenses and other current liabilities 0 742
Right-of-use assets under operating leases $ 7,814 $ 0